PDE1C and atherosclerosis: In the context of HASMC LEP formation, PDE1C is known to be induced in migratory and proliferative vascular SMCs [21,39,40], thus this signaling axis provides a potential molecular target to mitigate vascular diseases where SMC migration is dysregulated, such as atherosclerosis and restenosis.